2018•Evidence-Based PracticeRequires access

Are phosphodiesterase inhibitors effective and safe for men with diabetes and erectile dysfunction?

Boris Bayerman, Gina G. Glass, Aarti Aggarwal

Open publisher page 0 citations

Abstract

EVIDENCE-BASED ANSWER Yes. As-needed use of sildenafil, tadalafil, and vardenafil lead to large improvements in erectile function in men with diabetes. Tadalafil taken daily results in nearly 20% more men able to complete intercourse, but only marginal clinical benefit in overall erectile function compared with placebo. Adverse events occur up to twice as often with phosphodiesterase type 5 (PDE-5) inhibitors than placebo, but are minor such as headache and dyspepsia (SOR: A, meta-analyses of RCTs). Vardenafil taken daily improves global erectile function scores, with mean scores at the level considered to be normal erectile function (SOR: B, single RCT).

About this research paper

What this paper is about

EVIDENCE-BASED ANSWER Yes. As-needed use of sildenafil, tadalafil, and vardenafil lead to large improvements in erectile function in men with diabetes. Tadalafil taken daily results in nearly 20% more men able to complete intercourse, but only marginal clinical benefit in overall erectile function compared with placebo. Adverse events occur up to twice as often with phosphodiesterase type 5 (PDE-5) inhibitors than placebo, but are minor such as headache and dyspepsia (SOR: A, meta-analyses of RCTs). Vardenafil taken daily improves global erectile function scores, with mean scores at the level considered to be normal erectile function (SOR: B, single RCT).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

EVIDENCE-BASED ANSWER Yes. As-needed use of sildenafil, tadalafil, and vardenafil lead to large improvements in erectile function in men with diabetes. Tadalafil taken daily results in nearly 20% more men able to complete intercourse, but only marginal clinical benefit in overall erectile function compared with placebo. Adverse events occur up to twice as often with phosphodiesterase type 5 (PDE-5) inhibitors than placebo, but are minor such as headache and dyspepsia (SOR: A, meta-analyses of RCTs). Vardenafil taken daily improves global erectile function scores, with mean scores at the level considered to be normal erectile function (SOR: B, single RCT).

Key concepts: Tadalafil, Vardenafil, Erectile dysfunction, cGMP-specific phosphodiesterase type 5, Sildenafil, Medicine, Placebo, Erectile function

Related papers

Back to paper searchBrowse research topicsOriginal source
Are phosphodiesterase inhibitors effective and safe for men with diabetes and erectile dysfunction? — Research Paper | ScholarLens